Growth among all of its product segments powered Eckert & Ziegler Group to increased revenues and profits in the first six months of 2011 (end-June 30).
The parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products increased revenues by 5% to 55.8 million euros ($78.1 million U.S.) in the six-month period, compared with 52.8 million euros ($73.9 million U.S.) in the same period of 2010.
Profit after taxes increased by 28% to 6.6 million euros ($9.2 million U.S.), compared with 5 million euros ($7 million U.S.) in last year's six-month period.
The company's Isotope Products segment accounted for the greatest share of the total results, with revenue rising by 9%.
